These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1500 related items for PubMed ID: 8623181

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.
    Clayton PA, McDonald SP, Chapman JR, Chadban SJ.
    Transplantation; 2012 Jul 27; 94(2):152-8. PubMed ID: 22728292
    [Abstract] [Full Text] [Related]

  • 24. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2001 Jul 27; 72(2):245-50. PubMed ID: 11477347
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE.
    Transplantation; 2003 Jun 27; 75(12):2048-53. PubMed ID: 12829910
    [Abstract] [Full Text] [Related]

  • 27. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
    Oh JM, Wiland AM, Klassen DK, Weidle PJ, Bartlett ST.
    J Clin Pharmacol; 2001 Aug 27; 41(8):861-9. PubMed ID: 11504274
    [Abstract] [Full Text] [Related]

  • 28. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
    Satoh S, Tada H, Murakami M, Tsuchiya N, Inoue T, Togashi H, Matsuura S, Hayase Y, Suzuki T, Habuchi T.
    Transplant Proc; 2005 May 27; 37(4):1751-3. PubMed ID: 15919454
    [Abstract] [Full Text] [Related]

  • 29. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F, Serón D, Morales JM, Cruzado JM, Gil-Vernet S, Pérez JL, Fulladosa X, Andrés A, Grinyó JM.
    Clin Transplant; 1998 Jun 27; 12(3):198-205. PubMed ID: 9642510
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J.
    Nephrol Dial Transplant; 1998 Oct 27; 13(10):2601-4. PubMed ID: 9794567
    [Abstract] [Full Text] [Related]

  • 32. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
    Zhu B, Liu Z, Wu C, Wang P, Wang X, Xu H.
    Transplant Proc; 2008 Sep 27; 40(7):2258-61. PubMed ID: 18790207
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ, Waters PF, Levine M, Kramer M, Ruzevich S, Kass RM.
    J Heart Lung Transplant; 1998 Aug 27; 17(8):768-74. PubMed ID: 9730425
    [Abstract] [Full Text] [Related]

  • 36. [Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group].
    Carl S, Wiesel M, Staehler G.
    Urologe A; 1998 May 27; 37(3):282-6. PubMed ID: 9646426
    [Abstract] [Full Text] [Related]

  • 37. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N, Kes P, Bubic-Filipi LJ, Puretic Z, Brunetta B, Pasini J.
    Transplant Proc; 2005 Mar 27; 37(2):850-1. PubMed ID: 15848553
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation.
    Wüthrich RP, Cicvara S, Ambühl PM, Binswanger U.
    Nephrol Dial Transplant; 2000 Aug 27; 15(8):1228-31. PubMed ID: 10910450
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 75.